Relay Therapeutics, Inc. (RLAY)
18.91
-0.05
(-0.26%)
USD |
NASDAQ |
Oct 05, 13:19
Relay Therapeutics Total Liabilities (Quarterly) : 77.45M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 77.45M |
| March 31, 2026 | 57.43M |
| December 31, 2025 | 54.27M |
| September 30, 2025 | 62.29M |
| June 30, 2025 | 63.18M |
| March 31, 2025 | 78.28M |
| December 31, 2024 | 93.50M |
| September 30, 2024 | 91.25M |
| June 30, 2024 | 90.81M |
| March 31, 2024 | 95.68M |
| December 31, 2023 | 91.98M |
| September 30, 2023 | 128.59M |
| June 30, 2023 | 151.90M |
| March 31, 2023 | 154.15M |
| Date | Value |
|---|---|
| December 31, 2022 | 149.55M |
| September 30, 2022 | 168.95M |
| June 30, 2022 | 109.78M |
| March 31, 2022 | 107.91M |
| December 31, 2021 | 110.64M |
| September 30, 2021 | 100.53M |
| June 30, 2021 | 95.87M |
| March 31, 2021 | 38.56M |
| December 31, 2020 | 36.54M |
| September 30, 2020 | 38.16M |
| June 30, 2020 | 35.65M |
| March 31, 2020 | 34.84M |
| December 31, 2019 | 35.72M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| SELLAS Life Sciences Group, Inc. | 7.726M |
| Karyopharm Therapeutics, Inc. | 441.48M |
| Spyre Therapeutics, Inc. | 71.86M |
| Akebia Therapeutics, Inc. | 324.64M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 967.46M |
| Shareholders Equity (Quarterly) | 890.01M |
| Debt to Equity Ratio | 0.0344 |
| Current Ratio | 18.27 |
| Net Debt Paydown Yield | 0.08% |